Associate Clinical Professor of Medicine, Dana-Farber Cancer Institute
Oncology
Dr. Leroy M. Parker, MD
|
|
Give Review
Leroy M. Parker practices Oncology. He graduated from Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He over the years received 1 awards: "Super Doctor". Leroy Parker is a published doctor and has 11 publications published. The lastest was: 'A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes.' Doctor Leroy M. Parker, MD accepts Medicare.
Publications
- A randomized, placebo-controlled trial of melatonin on breast Cancer survivors: impact on sleep, mood, and hot flashes.
- Noninvasive Prediction of Fracture Risk in Patients with Metastatic Cancer to the Spine.
- VEGF as a marker for outcome among advanced breast Cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.
- Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast Cancer: unexpected incidence of hypersensitivity reactions.
- Molecular definition of Breast tumor heterogeneity.
- Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for Stage II or III breast Cancer.
- Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast Cancer chemotherapy.
- Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast Cancer...
- Fulvestrant: clinical application of an estrogen receptor downregulator.
- Sequencing of hormonal therapy in postmenopausal women with metastatic breast Cancer.
Schools
Johns Hopkins University School Of Medicine
Johns Hopkins Hospital
Brigham Womens Hospital
National Institute HlthNiammd
Dana Farber Cancer Institute
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Super Doctor
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
Massachusetts General Hospital -
Dana-Farber Cancer Institute -
Brigham and Women's Faulkner Hospital -
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1629046776 | |
| NPPES Provider LastName | PARKER | |
| NPPES Provider FirstName | LEROY | |
| NPPES Provider ZIPCode | 022155418 | |
| NPPES Provider State | MA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 236.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 4.66 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629046776 |
| Last Name Of The Provider | PARKER |
| First Name Of The Provider | LEROY |
| View All |
Similar Doctors
|
|
Dr. Benjamin L. Schlechter, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paiman P. Ghoroghchian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rinath M. Jeselsohn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Jackman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Wendy S. Garrett, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Brian M. Wolpin, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Nageatte Ibrahim, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rochelle G. Scheib, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sigurdis Haraldsdottir, MD |